Computed Tomography

Cardiac computed tomography (CT) has become a primary cardiovascular imaging modality in the past 20 years, and was recommended as a 1A recommendation in the 2021 chest pain assessment guidelines. CT calcium scoring has became a primary risk assessment for coronary artery disease and whether patients should be on statins. Coronary CT angiography (CCTA) is used to for anatomical assessment of the arteries for plaque burden and to identify areas of blockage that may cause ischemia and heart attacks. Additional use of contrast CT perfusion or fractional flow reserve CT (FFR-CT) can offer physiological information on the function of the heart. CT plays a primary role in structural heart assessments for heart valves, repair of congenital defects and left atrial appendage occlusion (LAAO) for both pre-procedure planning and procedural guidance. Find more news on general radiology CT use.

AI improves CT assessments, boosts care for real-world heart patients
Automated AI-generated measurements combined with annotated CT images can improve treatment planning and help referring physicians and patients better understand their disease, explained Sarah Jane Rinehart, MD, director of cardiac imaging with Charleston Area Medical Center.
AI predicts cardiovascular risk during CT scans—no invasive tests or contrast required
Two advanced algorithms—one for CAC scores and another for segmenting cardiac chamber volumes—outperformed radiologists when assessing low-dose chest CT scans.
CT procedure shown to reduce need for invasive cardiac testing
In a study, CT-FFR was shown to reduce the need for invasive tests to measure coronary artery blockage from 74.5% to 25.5%.
First-in-human trial shows potential of guiding CABG with cardiac CT and AI—no ICA required
An independent heart team blinded to ICA results was able to deliver helpful guidance for CABG procedures for 99.1% of patients using just CCTA and FFR_CT alone. This approach is safe and feasible, researchers wrote, and the next step is to gather additional data.
Radiology AI company gains FDA clearance for new CT offerings focused on PE, stroke
The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.

Ron Blankstein, MD, MSCCT, associate director, cardiovascular imaging program, director, cardiac computed tomography, Brigham and Women's Hospital, and professor of medicine, Harvard Medical School, was a co-author on the ACC 2021 Chest Pain Guidelines,[1] which now lists coronary computed tomography angiography (CCTA or CTA) as a 1A level recommendation for front line imaging. He gave an overview of the guidelines during the 2022 Society of Cardiovascular CT (SCCT) meeting in July. #SCCT2022

VIDEO: The role of cardiac CT in the 2021 chest pain guidelines

Ron Blankstein, MD, associate director of the cardiovascular imaging program and director of the cardiac computed tomography program for Brigham and Women's Hospital, was a co-author on the ACC 2021 Chest Pain Guidelines, which now lists coronary computed tomography angiography (CCTA or CTA) as a 1A level recommendation for frontline imaging.

July 28, 2022

CT coronary artery calcium (CAC) scoring, also known as the Agatston score, to assess the risk a patient has for future heart attacks and help decide if a patient requires statins.

VIDEO: Current guidelines for the use of CT calcium scoring in preventive cardiology

Mike Shapiro, DO, MD, director of the Center for Prevention of Cardiovascular Disease at Wake Forest University, discusses the current guidelines for computed tomography (CT) calcium scoring as a screening test to assess heart attack risk.

July 27, 2022

AI cardiology vendor Cleerly offers an FDA-cleared coronary artery soft plaque assessment.

Cardiology startup raises $192M for AI-powered imaging assessments

The company has now raised $248M in total to help develop, commercialize and market its FDA-cleared technology.

July 26, 2022

Examples of new cardiac CT technologies at the 2022 SCCT meeting. Top left clockwise, realistic 3D rendering inside the heart, the GE Revolution Apex scanner, Cleerly's AI automated soft plaque assessment, and CT strain imaging from Medis. #SCCT #SCCT2022 #YesCCT #CTA #CCTA, new computed tomography technology

PHOTO GALLERY: Cardiac CT advances at SCCT 2022

View a variety of images from the 2022 Society of Cardiovascular Computed Tomography (SCCT) meeting in Las Vegas.

July 25, 2022

AI-generated coronary tree from a patient's CT scan showing a color code of areas of interest for plaque burden from the Cleerly software shown at SCCT 2022.

VIDEO: Why plaque composition CT imaging may be the future of cardiology

Former European Society of Cardiology president Prof. Jeroen Bax explains the difficulty in quantifying these plaques manually and how artificial intelligence may change this to allow rapid, detailed quantitative analysis.

July 22, 2022

Left, coronary CT angiography of a vessel showing plaque heavy calcium burden. Right, image showing color code of various types of plaque morphology showing the complexity of these lesions. The right image was processed using the FDA cleared, AI-enabled plaque assessment from Elucid.

Cardiac CT soft plaque assessment may offer paradigm shift for coronary disease screening

New artificial intelligence software that can evaluate coronary CT scans to automatically assess soft plaques were by far the biggest technology advance discussed at the Society of Cardiovascular Computed Tomography (SCCT) 2022 meeting.

July 20, 2022

VIDEO: Top 6 takeaways from the Society of Cardiovascular CT 2022 meeting

Eric Williamson, MD, MSCCT, the 2021-2022 president of the Society of Cardiovascular Computed Tomography (SCCT) and professor of radiology at Mayo Clinic, shared his key takeaways from the SCCT 2022 conference.

July 19, 2022

Examples of new plaque reporting in the CAD-RADS 2.0 document. Left, an example from CAD-RADS 2 / P2 plaque burden with mild coronary stenosis (25-49%). Right, example of a CAD-RADS 5/ P3, with a focal, non-calcified occlusion of the proximal RCA (arrow) and severe amount of plaque (P3). #CADRADS #YesCCT #CTA #CCTA

New CAD-RADS 2.0 reporting for coronary CTA offers patient management recommendations

The document includes updated classification to established a framework for stenosis, plaque burden and plaque modifiers, including assessment of CT-FFR or myocardial CT perfusion.

July 8, 2022

Around the web

Cardiovascular Business

AI improves CT assessments, boosts care for real-world heart patients

Automated AI-generated measurements combined with annotated CT images can improve treatment planning and help referring physicians and patients better understand their disease, explained Sarah Jane Rinehart, MD, director of cardiac imaging with Charleston Area Medical Center.

Cardiovascular Business

AI predicts cardiovascular risk during CT scans—no invasive tests or contrast required

Two advanced algorithms—one for CAC scores and another for segmenting cardiac chamber volumes—outperformed radiologists when assessing low-dose chest CT scans.

Radiology Business

Google teams with Bayer to address radiologist burnout via AI

"Gen AI can help tackle repetitive tasks and provide insights into massive datasets, saving valuable time," Thomas Kurian, CEO of Google Cloud, said Tuesday.